Challenges in the discovery of tumor-specific alternative splicing-derived cell-surface antigens in glioma
Takahide Nejo(University of California, San Francisco), Hideho Okada(University of California, San Francisco)
Cited by 5
Related Papers
Induction of CD8<sup>+</sup>T-Cell Responses Against Novel Glioma–Associated Antigen Peptides and Clinical Activity by Vaccinations With α-Type 1 Polarized Dendritic Cells and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Patients With Recurrent Malignant Glioma
|Journal of Clinical Oncology|2010|561
Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomas
|Journal of Clinical Investigation|2017|411
Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy
|The Journal of Experimental Medicine|2017|215